Publications by authors named "Anjana Kushwaha"

The accurate prediction of peptide-major histocompatibility complex (MHC) class I binding probabilities is a critical endeavor in immunoinformatics, with broad implications for vaccine development and immunotherapies. While recent deep neural network based approaches have showcased promise in peptide-MHC (pMHC) prediction, they have two shortcomings: (i) they rely on hand-crafted pseudo-sequence extraction, (ii) they do not generalize well to different datasets, which limits the practicality of these approaches. While existing methods rely on a 34 amino acid pseudo-sequence, our findings uncover the involvement of 147 positions in direct interactions between MHC and peptide.

View Article and Find Full Text PDF

(Hc) (commonly known as Gulbakawali) leaf extract was used for the stable and sustainable green synthesis of silver nanoparticles (Hc-AgNPs), which were biodegradable and non-toxic. leaf extract was used as a reducing agent to stabilize the Hc-AgNPs by converting Ag to Ag without adding any capping agent. It demonstrated stability for up to six months, and no agglomeration was observed.

View Article and Find Full Text PDF

Background: Cancer cells activate different immune checkpoint (IC) pathways in order to evade immunosurveillance. Immunotherapies involving ICs either block or stimulate these pathways and enhance the efficiency of the immune system to recognize and attack cancer cells. In this way, the development of monoclonal antibodies (mAbs) targeting ICs has significant success in cancer treatment.

View Article and Find Full Text PDF
Article Synopsis
  • * The system provides scientific resources like databases, tools, and reference directories based on IMGT-ONTOLOGY to help researchers understand immune responses.
  • * Research is organized into three main areas: identifying immunoglobulin and T cell receptor genes (Axis I), analyzing immune repertoires in various conditions (Axis II), and studying structural changes and engineering of antibodies and T cell receptors (Axis III).
View Article and Find Full Text PDF